HQY logo

HealthEquity, Inc. (HQY) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

HQY, 82.47$ (piyasa değeri $7.05B) fiyatla Healthcare işi olan HealthEquity, Inc.'i temsil ediyor. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 59/100 puan alıyor.

Son analiz: 8 Şub 2026
59/100 AI Puanı Hedef $103.86 (+25.9%) PD $7.05B Hacim 799.0K

HealthEquity, Inc. (HQY) Sağlık ve Boru Hattı Genel Bakışı

CEOScott R. Cutler
Çalışanlar3105
MerkezDraper, UT, US
Halka Arz Yılı2014
SektörHealthcare

HealthEquity empowers consumers with innovative, cloud-based platforms for health savings and spending, driving efficiency and transparency in healthcare finance, and capturing a significant share of the growing HSA market with a focus on technology and customer service.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 8 Şub 2026

Yatırım Tezi

HealthEquity presents a notable research candidate due to its leading position in the rapidly expanding HSA market. The company's robust technology platform, coupled with its focus on customer service, drives strong customer retention and organic growth. With a market capitalization of $6.87 billion and a profit margin of 14.9%, HealthEquity demonstrates financial stability and profitability. Key value drivers include increasing HSA adoption rates, rising healthcare costs, and the company's ability to cross-sell additional services to its existing customer base. Upcoming catalysts include continued expansion of its network of partners and the introduction of new technology-driven solutions. Investors may want to evaluate HealthEquity for its long-term growth potential and its ability to capitalize on the evolving healthcare landscape.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market Cap of $6.87B reflects investor confidence in HealthEquity's growth potential and market leadership.
  • P/E ratio of 35.62 indicates a premium valuation, reflecting expectations of future earnings growth.
  • Profit Margin of 14.9% demonstrates the company's ability to generate profits from its operations.
  • Gross Margin of 61.5% highlights the efficiency of HealthEquity's service delivery and pricing strategy.
  • Beta of 0.24 suggests that the stock is significantly less volatile than the overall market, making it a noteworthy option for risk-averse investors.

Rakipler & Benzerleri

Güçlü Yönler

  • Leading market position in the HSA market.
  • Strong technology platform and customer service.
  • Recurring revenue model with high customer retention.
  • Experienced management team.

Zayıflıklar

  • Dependence on regulatory environment and healthcare reform.
  • Exposure to interest rate risk.
  • Competition from larger players in the healthcare industry.
  • Potential for data breaches and security vulnerabilities.

Katalizörler

  • Ongoing: Continued growth in HSA adoption rates.
  • Ongoing: Expansion of HealthEquity's network of partners.
  • Upcoming: Launch of new technology-driven solutions.
  • Ongoing: Increasing healthcare costs driving demand for HSA solutions.

Riskler

  • Potential: Changes in healthcare regulations could negatively impact the HSA market.
  • Potential: Increased competition could erode HealthEquity's market share.
  • Potential: Economic downturn could reduce healthcare spending.
  • Ongoing: Cybersecurity threats and data breaches could damage HealthEquity's reputation.

Büyüme Fırsatları

  • Expansion of HSA Market: The HSA market is projected to continue its rapid growth trajectory as more employers and individuals adopt HSAs as a cost-effective healthcare savings solution. HealthEquity is well-positioned to capitalize on this trend by expanding its customer base and increasing its market share. The total addressable market for HSAs is estimated to be in the tens of billions of dollars, providing ample opportunity for HealthEquity to grow its revenue and profitability.
  • Strategic Partnerships: HealthEquity can further expand its reach and market penetration by forging strategic partnerships with health plans, benefits administrators, and other key players in the healthcare ecosystem. These partnerships can provide access to new customer segments and distribution channels, accelerating HealthEquity's growth. The company's existing network of partners provides a solid foundation for building new relationships and expanding its market presence.
  • Product Innovation: HealthEquity can drive growth by continuously innovating and expanding its product offerings. This includes developing new technology-driven solutions that enhance the user experience, improve healthcare outcomes, and drive cost savings. The company's investment in research and development will be critical to maintaining its competitive edge and capturing new market opportunities. Focus on AI and machine learning to provide personalized recommendations and insights could be a key differentiator.
  • Cross-Selling Opportunities: HealthEquity has significant opportunities to cross-sell additional services to its existing customer base. This includes offering flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other related services. By leveraging its existing customer relationships, HealthEquity can increase its revenue per customer and improve its overall profitability. Focus on integrated solutions that bundle multiple services together could be a key driver of growth.
  • Mergers and Acquisitions: HealthEquity can pursue strategic mergers and acquisitions to expand its market share, acquire new technologies, and enter new markets. The company's strong financial position provides it with the flexibility to pursue these opportunities. Acquisitions of smaller players in the HSA market or companies with complementary technologies could be particularly attractive.

Fırsatlar

  • Expansion of the HSA market.
  • Strategic partnerships with health plans and benefits administrators.
  • Product innovation and cross-selling opportunities.
  • Mergers and acquisitions.

Tehditler

  • Increased competition from new entrants.
  • Changes in healthcare regulations.
  • Economic downturn and reduced healthcare spending.
  • Cybersecurity threats and data breaches.

Rekabet Avantajları

  • Switching Costs: High switching costs due to the complexity of transferring HSA accounts and the disruption to employees.
  • Network Effect: A growing network of partners and customers creates a strong network effect, making the platform more valuable to all users.
  • Scale: HealthEquity's scale provides it with a cost advantage over smaller competitors.
  • Technology: Proprietary technology platform that is difficult to replicate.

HQY Hakkında

HealthEquity, Inc., founded in 2002 and headquartered in Draper, Utah, is a technology-enabled services platform provider focused on empowering individuals to make informed healthcare decisions. The company's core offering revolves around cloud-based platforms that allow consumers and employers to manage health savings and spending. These platforms facilitate various activities, including paying healthcare bills, comparing treatment options and prices, accessing personalized benefit and clinical information, earning wellness incentives, growing savings, and making investment choices through health savings accounts (HSAs). HealthEquity's evolution has been marked by a commitment to simplifying the complexities of healthcare finance. Beyond HSAs, the company provides a mutual fund investment platform and online-only automated investment advisory services through its Advisor tool. Additionally, HealthEquity offers flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and Consolidated Omnibus Budget Reconciliation Act (COBRA) continuation services, along with pre-tax commuter benefit program administration. The company serves its clients through a multi-channel approach, including a direct sales force, benefits brokers and advisors, and a network of health plans, benefits administrators, brokers, consultants, and retirement plan record-keepers. HealthEquity's competitive positioning is strengthened by its comprehensive suite of services and its focus on technology-driven solutions that enhance user experience and drive efficiency.

Ne Yaparlar

  • Provide cloud-based platforms for managing health savings and spending.
  • Offer health savings accounts (HSAs) to consumers and employers.
  • Facilitate healthcare bill payments and treatment price comparisons.
  • Deliver personalized benefit and clinical information.
  • Administer flexible spending accounts (FSAs) and health reimbursement arrangements (HRAs).
  • Provide COBRA continuation services.
  • Administer pre-tax commuter benefit programs.

İş Modeli

  • Generate revenue from fees charged for administering HSAs and other benefit accounts.
  • Earn interest income on deposits held in HSAs.
  • Receive interchange fees from debit card transactions made through HSAs.
  • Offer investment advisory services through its Advisor platform.

Sektör Bağlamı

HealthEquity operates within the healthcare information services industry, which is experiencing significant growth due to increasing demand for technology-enabled solutions that improve healthcare efficiency and transparency. The HSA market is expanding rapidly as employers and individuals seek ways to manage healthcare costs effectively. HealthEquity's competitors include companies like BIO, BTSG, CORT, DVA, and GMED, but HealthEquity differentiates itself through its comprehensive suite of services and its focus on technology-driven solutions. The industry is characterized by increasing regulatory scrutiny and a growing emphasis on data security and privacy.

Kilit Müşteriler

  • Employers of all sizes seeking to offer HSAs and other benefits to their employees.
  • Individual consumers looking to save and pay for healthcare expenses.
  • Health plans and benefits administrators who partner with HealthEquity to offer HSA solutions.
  • Benefits brokers and consultants who recommend HealthEquity to their clients.
AI Güveni: 73% Güncellendi: 8 Şub 2026

Finansallar

Grafik & Bilgi

HealthEquity, Inc. (HQY) hisse senedi fiyatı: $82.47 (+0.00, +0.00%)

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

HQY için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

Konsensüs hedefi: $103.86

MoonshotScore

59/100

Bu puan ne anlama geliyor?

MoonshotScore, HQY'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

HQY Healthcare Hisse Senedi SSS

HQY için değerlendirilmesi gereken temel faktörler nelerdir?

HealthEquity, Inc. (HQY) şu anda yapay zeka skoru 59/100, orta puanı gösteriyor. Analist hedefi $103.86 ($82.47'dan +26%). Temel güçlü yan: Leading market position in the HSA market.. İzlenmesi gereken birincil risk: Potential: Changes in healthcare regulations could negatively impact the HSA market.. Bu bir finansal tavsiye değildir.

HQY MoonshotScore'u nedir?

HQY şu anda MoonshotScore'da 59/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

HQY verileri ne sıklıkla güncellenir?

HQY fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler HQY hakkında ne diyor?

Analistler, HQY için $103.86 konsensüs fiyat hedefi belirledi, bu mevcut fiyattan ($82.47) yukarı yönlü %26 potansiyeli temsil ediyor. Kapsam, al, tut ve sat derecelendirmelerini, kazanç tahminlerini ve son yükseltmeleri veya düşürmeleri içerir. Tüm ayrıntılar için bu sayfadaki Analist Konsensüsü bölümüne bakın.

HQY'a yatırım yapmanın riskleri nelerdir?

HQY için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Changes in healthcare regulations could negatively impact the HSA market.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

HQY'ın P/E oranı nedir?

HQY için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için HQY'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

HQY aşırı değerli mi, yoksa düşük değerli mi?

HealthEquity, Inc. (HQY)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Analist hedefi $103.86 (mevcut fiyattan +26%), analistlerin yukarı yönlü potansiyel gördüğünü gösteriyor. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

HQY'ın temettü verimi nedir?

HealthEquity, Inc. (HQY) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Fiyat itibarıyla Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Stock data pending update.
Veri Kaynakları

Popüler Hisseler